Genomic and Phenotypic Evolution of Tigecycline-Resistant Acinetobacter baumannii in Critically Ill Patients

Authors:

Abstract
Multidrug-resistant Acinetobacter baumannii poses a huge challenge to clinical treatment, and tigecycline is considered a last-line drug for the treatment of multidrug-resistant A. baumannii . However, the mechanism of tigecycline resistance in vivo has not been elucidated.
Funding Information
  • National Natural Science Foundation of China (81871693)
  • National Natural Science Foundation of China (81991533)
  • Peking University People's Hospital (RS2018-03)

This publication has 48 references indexed in Scilit: